iSpecimen
ISPC
7 hedge funds and large institutions have $8.1M invested in iSpecimen in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
17.28% more ownership
Funds ownership: 0% → 17.28% (+17%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
+$4.32M |
| 2 |
NAM
NewGen Asset Management
Toronto,
Ontario, Canada
|
+$1.8M |
| 3 |
KC
Kepos Capital
New York
|
+$1.62M |
| 4 |
Jane Street
New York
|
+$207K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$86.4K |
Top Sellers
ISPC Hedge Fund Activity: Q2 2021 in Review
7 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q2 2021, worth a combined $8.1M.
Buyers outnumbered sellers: 7 funds opened new ISPC positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bleichroeder LP, opening a new position worth an estimated $4.32M.
- 7 institutional investors held iSpecimen (ISPC) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $8.1M of iSpecimen stock for Q2 2021.
- 7 funds opened new iSpecimen positions in Q2 2021 and 0 closed out, a net change of +7 holders.
- The largest iSpecimen buyer in Q2 2021 was Bleichroeder LP, an estimated $4.32M added.
Based on aggregated 13F filings for Q2 2021.